<DOC>
	<DOCNO>NCT00755820</DOCNO>
	<brief_summary>This research study determine whether medication call D-cycloserine ( DCS ) combination type psychotherapy call Exposure Therapy helpful patient anorexia nervosa .</brief_summary>
	<brief_title>Food Exposure Therapy Anorexia Nervosa</brief_title>
	<detailed_description>This research study determine whether medication call D-cycloserine ( DCS ) combination type psychotherapy call Exposure Therapy helpful patient anorexia nervosa . DCS approve FDA antibiotic medication , approve FDA treatment anorexia nervosa . Past study find DCS together Exposure Therapy help people height phobia , social phobia , obsessive compulsive disorder . Anorexia nervosa often include phobia-like fear , obsessive thought , compulsive ritual , current study aim determine whether DCS pair Exposure Therapy also help people anorexia nervosa . Anorexia nervosa disorder characterize self-starvation , extreme weight loss , difficulty maintain normal weight . You ask participate study give diagnosis anorexia nervosa . In study receive one three therapy : Exposure Therapy DCS , Exposure Therapy placebo ( inactive medication ) , Treatment Usual . You participate total four test meal laboratory set . A total 70 individual anorexia nervosa participate study . Twenty individual never eat disorder participate one portion study .</detailed_description>
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Inclusion Criteria Patients : DSMIVTR™ diagnosis anorexia nervosa ( restrict bingepurge subtype ) admission Subjects achieve 90 % ideal body weight ( IBW ) Age 1845 Medically stable Participation inpatient treatment Subjects must sign informed consent document indicate understand purpose procedure require study willing participate study . Exclusion Criteria Patients : Any current major Axis I disorder , except OCD MDD ( mild ) On psychotropic medication , include benzodiazepine ( At start study , subject free fluoxetine 4 week , free medication minimum 2 week . ) History seizure disorder Abnormal liver function Renal insufficiency Known hypersensitivity Dcycloserine Pregnant lactate Acute suicidality ( suicidality self injury last 3 month ) Inclusion Criteria Healthy Controls : BMI ≥ 19.0 kg/m2 Age 1845 year Subjects must sign informed consent document indicate understand purpose procedure require study willing participate study . Exclusion Criteria Healthy Controls : Current Major Axis I disorder ( include Eating Disorder , Major Depression , Bipolar Disorder , Schizophrenia , Substance Abuse/Dependence ) History Eating Disorder Current use psychotropic medication medication know affect mood and/or anxiety ( e.g . bagonist inhaler , oral steroid ) Major medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>